TUDOR INVESTMENT CORP ET AL - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 134 filers reported holding PDL BIOPHARMA INC in Q1 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2021$83,000
+33.9%
33,559
+69.2%
0.00%
-66.7%
Q3 2020$62,000
-60.0%
19,830
-62.8%
0.00%
-62.5%
Q2 2020$155,000
-30.8%
53,301
-32.9%
0.01%
-60.0%
Q1 2020$224,000
-39.3%
79,424
-30.2%
0.02%
+17.6%
Q4 2019$369,000
+29.5%
113,734
-13.7%
0.02%
+70.0%
Q3 2019$285,000
+119.2%
131,777
+277.2%
0.01%
+100.0%
Q1 2019$130,000
+261.1%
34,938
+183.0%
0.01%
+400.0%
Q4 2018$36,000
+5.9%
12,345
-4.6%
0.00%0.0%
Q3 2018$34,000
-46.0%
12,943
-39.4%
0.00%
-50.0%
Q1 2018$63,000
-87.0%
21,351
-90.0%
0.00%
-86.7%
Q1 2017$484,000
-21.9%
213,284
-27.1%
0.02%
-6.2%
Q4 2016$620,000
+104.6%
292,400
+223.8%
0.02%
+128.6%
Q3 2016$303,000
+4.5%
90,300
+3.7%
0.01%0.0%
Q1 2016$290,000
-35.0%
87,100
-30.8%
0.01%
-46.2%
Q4 2015$446,000
+97.3%
125,900
+180.4%
0.01%
+62.5%
Q3 2015$226,000
-59.6%
44,900
-48.4%
0.01%
-50.0%
Q2 2015$559,000
-32.8%
87,000
-26.4%
0.02%
-40.7%
Q1 2015$832,000
+57.9%
118,200
+73.1%
0.03%
+50.0%
Q4 2014$527,000
-43.9%
68,300
-45.8%
0.02%
-47.1%
Q3 2014$940,000
+91.8%
125,900
+148.8%
0.03%
+78.9%
Q2 2014$490,000
-28.5%
50,600
-38.6%
0.02%
-34.5%
Q1 2014$685,000
-14.1%
82,400
-12.7%
0.03%
-25.6%
Q4 2013$797,000
+246.5%
94,400
+226.6%
0.04%
+333.3%
Q3 2013$230,000
-54.9%
28,900
-56.3%
0.01%
-76.3%
Q2 2013$510,00066,1000.04%
Other shareholders
PDL BIOPHARMA INC shareholders Q1 2020
NameSharesValueWeighting ↓
Nine Chapters Capital Management LLC 119,700$254,0000.43%
GSA CAPITAL PARTNERS LLP 1,587,756$3,366,0000.20%
AMERICAFIRST CAPITAL MANAGEMENT, LLC 60,901$129,110,0000.14%
Acrospire Investment Management LLC 129,480$274,0000.11%
SECOR Capital Advisors, LP 410,323$870,0000.11%
RBF Capital, LLC 251,421$540,0000.08%
Park West Asset Management LLC 400,000$848,0000.07%
MACKENZIE FINANCIAL CORP 4,687,825$9,938,0000.06%
CIGNA INVESTMENTS INC /NEW 261,533$554,000,0000.06%
ACADIAN ASSET MANAGEMENT LLC 5,503,285$11,665,0000.06%
View complete list of PDL BIOPHARMA INC shareholders